Aragen Life Science, formerly GVK Biosciences, secures a $100 million investment from healthcare-focused private equity fund Quadria Capital. The investment will support Aragen’s strategic expansion and infrastructure development to meet growing demand for outsourcing services from US and Europe innovators. This move positions Aragen strongly in the pharmaceutical outsourcing market, enhancing its capabilities and accelerating program delivery.
Related Posts
Magenta Mobility to add 10,000 EVs over next fiscal; to expand to new cities
Magenta Mobility is set to expand its electric vehicle fleet by 10,000 three- and four-wheelers in the next financial year. The company is targeting new […]
India secures $386 billon funding for renewable energy expansion by 2030
India has secured $386 billion from financial institutions to increase its renewable energy capacity by 2030. Union minister Pralhad Joshi highlighted commitments from states, developers, […]